DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
W••••••••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Sep 30, 2025sponsor unattributed
Nothing material in the last 200 days. Last change: 30 Sep 2025, $960K principal held by 1 lender; matures Mar 2028.
Mark path, consensus per quarter end
99¢ · 99¢ · 99¢ · 98¢ · 99¢Q3 2024 to Q3 2025
Principal held
at least $960,067
sum of BDC pieces, a lower bound
Fair value
$943,265
99c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
1
1 on the latest quarter
Facilities
1
0 equity pieces beside them
Next maturity
Mar 31, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Sep 30, 2025
Events
1
dated, non-routine
Lender marks
each lender's own fair value over cost at Sep 30, 2025, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• C••••• B•• I••• | $960K | 99¢ | +1 pts |
Every BDC piece · 1 position across 1 lenderlargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• C••••• B•• I••• | term loan first lien Investment T••• S••••• S•••••• I•••••• T••• L••• I•••• S+ S••••• 4.50% I••••••• R••• 8.48% | $960,067 | $943,265 99c | SOFR+450 bp |
Capital structure as the BDCs see it
latest quarter end Sep 30, 2025
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Sep 30, 2025 | at least $960,067 | 99c | SOFR+450 bp | Mar 31, 2028 | 1 |
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2025 | 1 | $960,067 | $943,265 | 99c | 0 |
| Jun 30, 2025 | 1 | $962,544 | $943,294 | 98c | 0 |
| Mar 31, 2025 | 1 | $965,022 | $950,547 | 99c | 0 |
| Dec 31, 2024 | 1 | $1.9M | $1.9M | 99c | 0 |
All 11 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Sep 30, 2024 | 1 | $970,000 | $957,875 | 99c | 0 |
| Jun 30, 2024 | 1 | $972,500 | $961,559 | 100c | 0 |
| Mar 31, 2024 | 1 | $975,000 | $965,250 | 100c | 0 |
| Dec 31, 2023 | 1 | $2.0M | $1.9M | 100c | 0 |
| Sep 30, 2023 | 1 | $980,000 | $968,975 | 100c | 0 |
| Jun 30, 2023 | 1 | $982,500 | $975,131 | 100c | 0 |
| Dec 31, 2022 | 1 | $987,500 | $987,500 | 101c | 0 |
What changed
- Facility left every BDC scheduleSep 30, 2025
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- WEDGEWOODderivedthe codename stem after legal suffixes and deal words
- Spellings
- 1 across 1 BDCderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it